{
  "compound_id": "DB00317",
  "compound_name": "Gefitinib",
  "compound_percentile": 0.772058823529412,
  "disease_id": "DOID:11934",
  "disease_name": "head and neck cancer",
  "disease_percentile": 0.8283485045513649,
  "metapath_contribution": {
    "CbGaD": 0.4870925889848859,
    "CbGbCtD": 0.30752076802805456,
    "CbGdCrCtD": 0.003323457689081497,
    "CbGeAlD": 0.042201426846206404,
    "CbGpPWpGaD": 0.09206738325101396,
    "CcSEcCtD": 0.06279465731073516,
    "CrCbGaD": 0.0049997178900225885
  },
  "n_trials": 18.0,
  "prediction": 0.00224460191659591,
  "status": 0,
  "training_prediction": 0.00272404496601554
}